Core Viewpoint - LOBO EV Technologies Ltd. has entered a strategic partnership with Roundtree Lab to manufacture AI-driven medical beds, marking its entry into the healthcare equipment market with projected sales growth from $11 million in the first year to $88 million by the third year [2][4][5]. Group 1: Agreement Details - The definitive agreement solidifies the collaboration between LOBO and Roundtree, focusing on leveraging LOBO's manufacturing capabilities to produce advanced medical beds integrated with AI technology [3][4]. - LOBO will serve as the exclusive Original Equipment Manufacturer (OEM) for Roundtree's medical transfer beds, utilizing Roundtree's proprietary patents and licenses [8]. Group 2: Market Potential - The partnership targets the expanding U.S. medical device market, particularly in smart medical devices for elderly care and intelligent patient transport, with a significant opportunity in AI-driven emergency transfer beds [5]. - Roundtree aims to capture at least 50% of the U.S. emergency medical equipment market over the next three years, highlighting the transformative potential of the technology [5]. Group 3: Management Commentary - The CEO of LOBO expressed excitement about the partnership, emphasizing the alignment with the company's commitment to innovation and diversification in enhancing patient care [6]. - The CEO of Roundtree highlighted the collaboration as a significant milestone in revolutionizing healthcare through AI-driven solutions, citing LOBO's manufacturing excellence as a key factor [6].
LOBO EV Technologies Ltd. Announces Definitive Agreement with Roundtree Lab, LLC to Manufacture Medical Beds